Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of staphylococcus aureus

Microbial Drug Resistance

Volumn 20, Issue 3, 2014, Pages 238-249

  Figueiredo, Teresa A ^a   Ludovice, Ana Madalena ^a,b   Sobral, Rita G ^b  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; GLUTAMIC ACID; LYSOZYME; OXACILLIN; PEPTIDOGLYCAN; AMIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAM; PEPTIDE SYNTHASE; UDP-N-ACETYLMURAMOYLALANINE-D-GLUTAMATE LIGASE;

AMIDATION; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL VIABILITY; CELL WALL; CONFERENCE PAPER; GROWTH INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OPERON; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOUTHERN BLOTTING; ADAPTATION; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; TRANSPORT AT THE CELLULAR LEVEL;

ADAPTATION, PHYSIOLOGICAL; AMIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMS; BIOLOGICAL TRANSPORT; CELL WALL; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; METABOLIC NETWORKS AND PATHWAYS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MURAMIDASE; OPERON; PEPTIDE SYNTHASES; PEPTIDOGLYCAN;

EID: 84902201410     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2014.0042     Document Type: Conference Paper

References (52)

1. Aires-de-Sousa, M., B. Correia, H. de Lencastre, and Multilaboratory Project Collaborators. 2008. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: Surveillance over a 16-year period. J. Clin. Microbiol. 46: 2912-2917
2. Armand-Lefevre, L., R. Ruimy, and A. Andremont. 2005. Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg. Infect. Dis. 11:711-714
3. Bera, A., S. Herbert, A. Jakob, W. Vollmer, and F. Gotz. 2005. Why are pathogenic staphylococci so lysozyme resistant?. The peptidoglycan O-Acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 55:778-787
4. Berger-Bächi, B. 1983. Insertional inactivation of staphylococcal methicillin resistance by Tn551. J. Bacteriol. 154: 479-487
5. Berger-Bächi, B., A. Strässle, J.E. Gustafson, and F.H. Kayser. 1992. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1367-1373
6. Centers for Disease Control and Prevention. 1999. Four pediatric deaths from community acquired methicillinresistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 282:1123-1125
7. Chambers, H.F. 2001. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 7:178-182
8. Chung, M., H. de Lencastre, P. Matthews, A. Tomasz, I. Adamsson, M. Aires de Sousa, et al. 2000. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: Comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb. Drug Resist. 6:189-198
9. Collins, J., A. Buckling, and R.C. Massey. 2008. Identification of factors contributing to T-cell toxicity of Staphylococcus aureus clinical isolates. J. Clin. Microbiol. 46:2112-2114
10. Collins, J., J. Rudkin, M. Recker, C. Pozzi, J.P. O'Gara, and R.C. Massey. 2010. Offsetting virulence and antibiotic resistance costs by MRSA. ISME J 4:577-584
11. Conceiçäo, T., A. Tavares, M. Miragaia, K. Hyde, M. Aires-de-Sousa, and H. de Lencastre. 2010. Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: Predominance of SCCmec types IV, V and VI. Eur. J. Clin. Microbiol. Infect. Dis. 29:543-550
12. David, M.Z., and R.S. Daum. 2010. Community-Associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin. Microbiol. Rev. 23:616-687
13. De Lencastre, H., A.M. Figueiredo, and A. Tomasz. 1993. Genetic control of population structure in heterogeneous strains of methicillin resistant Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 12:13-18
14. De Lencastre, H., S.H. Wu, M.G. Pinho, A.M. Ludovice, S. Filipe, S. Gardete, R. Sobral, S. Gill, M. Chung, and A. Tomasz. 1999. Antibiotic resistance as a stress response: Complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb. Drug Resist. 5:163-175
15. DeLeo, F.R., M. Otto, B.N. Kreiswirth, and H.F. Chambers. 2010. Community-Associated meticillin-resistant Staphylococcus aureus. Lancet 375:1557-1568
16. Faria, N.A., D.C. Oliveira, H. Westh, D.L. Monnet, A.R. Larsen, R. Skov, and H. de Lencastre. 2005. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: A nationwide study in a country with low prevalence of MRSA infection. J. Clin. Microbiol. 43:1836-1842
17. Figueiredo, T.A., R.G. Sobral, A.M. Ludovice, J.M. Almeida, N.K. Bui, W. Vollmer, H. de Lencastre, and A. Tomasz. 2012. Identification of genetic determinants and enzymes involved with the amidation of glutamic acid residues in the peptidoglycan of Staphylococcus aureus. PLoS Pathog. 8:e1002508
18. Gordon, R.J., and F.D. Lowy. 2008 Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46:S350-S359
19. Herbert, S., A. Bera, C. Nerz, D. Kraus, A. Peschel, C. Goerke, M. Meehl, A. Cheung, and F. Gotz. 2007. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3:e102
20. Herold, B.C., L.C. Immergluck, M.C. Maranan, D.S. Lauderdale, R.E. Gaskin, S. Boyle-Vavra, C.D. Leitch, and R.S. Daum. 1998. Community-Acquired methicillinresistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279:593-598. (Pubitemid 28110205)
21. Horner, C., P. Parnell, D. Hall, A. Kearns, J. Heritage, and M. Wilcox. 2013. Meticillin-resistant Staphylococcus aureus in elderly residents of care homes: Colonization rates and molecular epidemiology. J. Hosp. Infect. 83:212-218
22. Katayama, Y., D.A. Robinson, M.C. Enright, and H.F. Chambers. 2005. Genetic background affects stability of mecA in Staphylococcus aureus. J. Clin. Microbiol. 43: 2380-2383
23. Katayama, Y., H.Z. Zhang, and H.F. Chambers. 2003. Effect of disruption of Staphylococcus aureus pbp4 gene on resistance to beta-lactam antibiotics. Microb. Drug Resist. 9:329-336
24. Klevens, R.M., M.A. Morrison, S.K. Fridkin, A. Reingold, S. Petit, K. Gershman, S. Ray, L.H. Harrison, R. Lynfield, G. Dumyati, J.M. Townes, A.S. Craig, G. Fosheim, L.K. McDougal, F.C. Tenover, and the Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2006. Community-Associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12:1991-1993
25. Kornblum, J., B.J. Hartman, R.P. Novick, and A. Tomasz. 1986. Conversion of a homogeneously methicillinresistant strain of Staphylococcus aureus to heterogeneous resistance by Tn551-mediated insertional inactivation. Eur. J. Clin. Microbiol. 5:714-718
26. Kos, V.N., C.A. Desjardins, A. Griggs, G. Cerqueira, A. Van Tonder, M.T. Holden, P. Godfrey, K.L. Palmer, K. Bodi, E.F. Mongodin, J. Wortman, M. Feldgarden, T. Lawley, S.R. Gill, B.J. Haas, B. Birren, and M.S. Gilmore. 2012. Comparative genomics of vancomycinresistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-Acquired infection in the United States. mBio 3:e00112-e00112
27. Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 20:520-532
28. Ludovice, A.M., S.W. Wu, and H. de Lencastre. 1998. Molecular cloning and DNA sequencing of the Staphylococcus aureus UDP-N-Acetylmuramyl tripeptide synthetase (murE) gene, essential for the optimal expression of methicillin resistance. Microb. Drug Resist. 4:85-90
29. Marchese, A., L. Gualco, E. Maioli, and E.E. Debbia. 2009. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: Emergence of USA300 and EMRSA-15 clones. Int. J. Antimicrob. Agents 34:424-428
30. Maugat, S., A. de Rougemont, H. Aubry-Damon, M.E. Reverdy, S. Georges, F. Vandenesch, J. Etienne, and B. Coignard. 2009. Methicillin-resistant Staphylococcus aureus among a network of French private-sector communitybased-medical laboratories. Med. Mal. Infect. 39:311-318
31. McDougal, L.K., C.D. Steward, G.E. Killgore, J.M. Chaitram, S.K. McAllister, and F.C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. J. Clin. Microbiol. 41: 5113-5120
32. Memmi, G., S.R. Filipe, M.G. Pinho, Z. Fu, and A. Cheung. 2008. Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-Acquired methicillin-resistant strains. Antimicrob. Agents Chemother. 52: 3955-3966
33. Moran, G.J., A. Krishnadasan, R.J. Gorwitz, G.E. Fosheim, L.K. McDougal, R.B. Carey, D.A. Talan, and EMERGEncy ID Net Study Group. 2006. Methicillinresistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674
34. Munch, D., T. Roemer, S.H. Lee, M. Engeser, H.G. Sahl, and T. Schneider. 2012. Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus. PLoS Pathog. 8: E1002509
35. Murakami, K., and A. Tomasz. 1989. Involvement of multiple genetic determinants in high-level methicillin resistance in Staphylococcus aureus. J. Bacteriol. 171:874-879. (Pubitemid 19053483)
36. Nair, D., G. Memmi, D. Hernandez, J. Bard, M. Beaume, S. Gill, P. Francois, and A.L. Cheung. 2011. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193:2332-2335
37. O'Brien, F.G., J.W. Pearman, M. Gracey, T.V. Riley, and W.B. Grubb. 1999. Community strain of methicillinresistant Staphylococcus aureus involved in a hospital outbreak. J. Clin. Microbiol. 37:2858-2862
38. Oliveira, D.C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: Molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189
39. Oliveira, D.C., A. Tomasz, and H. de Lencastre. 2001. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: Identification of two ancestral genetic backgrounds and the associated mec elements. Microb. Drug Resist. 7:349-361
40. Oliveira, D.C., I. Crisóstomo, I. Santos-Sanches, P. Major, C.R. Alves, M. Aires-de-Sousa, M.K. Thege, and H. de Lencastre. 2001. Comparison of DNA sequencing of the protein A gene polymorphic region with other molecular typing techniques for typing two epidemiologically diverse collections of methicillin-resistant Staphylococcus aureus. J. Clin.Microbiol. 39:574-580. (Pubitemid 32150820)
41. Oshida, T., and A. Tomasz. 1992. Isolation and characterization of a Tn551-Autolysis mutant of Staphylococcus aureus. J. Bacteriol. 174:4952-4959
42. Pereira, S.F., A.O. Henriques, M.G. Pinho, H. de Lencastre, and A. Tomasz. 2007. Role of PBP1 in cell division of Staphylococcus aureus. J. Bacteriol. 189:3525-3531. (Pubitemid 46668817)
43. Pinho, M.G., H. de Lencastre, and A. Tomasz. 2000. Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus. J. Bacteriol. 182:1074-1079. (Pubitemid 30075031)
44. Pinho, M.G., S.R. Filipe, H. de Lencastre, and A. Tomasz. 2001. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J. Bacteriol. 183:6525-6531. (Pubitemid 33026741)
45. Robinson, D.A., and M.C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934
46. Rolo, J., M. Miragaia, A. Turlej-Rogacka, J. Empel, O. Bouchami, N.A. Faria, A. Tavares, W. Hryniewicz, A.C. Fluit, H. de Lencastre, and CONCORD Working Group. 2012. High genetic diversity among communityassociated Staphylococcus aureus in Europe: Results from a multicenter study. PLoS One 7:e34768
47. Sá-Leäo, R., I. Santos Sanches, D. Dias, I. Peres, R.M. Barros, and H. de Lencastre. 1999. Detection of an archaic clone of Staphylococcus aureus with low-level resistance to methicillin in a pediatric hospital in Portugal and in international samples: Relics of a formerly widely disseminated straiñ. J. Clin. Microbiol. 37:1913-1920
48. Sobral, R.G., A.M. Ludovice, H. de Lencastre, and A. Tomasz. 2006. Role of murF in cell wall biosynthesis: Isolation and characterization of a murF conditional mutant of Staphylococcus aureus. J. Bacteriol. 188:2543-2553
49. Sobral, R.G., A.M. Ludovice, S. Gardete, K. Tabei, H. De Lencastre, and A. Tomasz. 2003. Normally functioning murF is essential for the optimal expression of methicillin resistance in Staphylococcus aureus. Microb. Drug Resist. 9:231-241
50. Tavares, A., M. Miragaia, J. Rolo, C. Coelho, H. de Lencastre, and CA-MRSA/MSSA working group. 2013. High prevalence of hospital-Associated methicillin-resistant Staphylococcus aureus in the community in Portugal: Evidence for the blurring of community-hospital boundaries. Eur. J. Clin. Microbiol. Infect. Dis. 32:1269-1283
51. Tonin, E., and A. Tomasz. 1986. Beta-lactam-specific resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 30:577-583
52. Zapun, A., J. Philippe, K.A. Abrahams, L. Signor, D.I. Roper, E. Breukink, and T. Vernet. 2013. In vitro reconstitution of peptidoglycan assembly from the Grampositive pathogen Streptococcus pneumoniae. ACS Chem. Biol. 8:2688-2696.